{"id":"NCT00696137","sponsor":"BioDelivery Sciences International","briefTitle":"Long-term Extension Study of BEMA™ Fentanyl","officialTitle":"Open-label, Long-term Extension Study for Treatment of Breakthrough Cancer Pain With BEMA™ Fentanyl","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-06","primaryCompletion":"2009-07","completion":"2009-07","firstPosted":"2008-06-12","resultsPosted":"2018-12-19","lastUpdate":"2019-09-24"},"enrollment":5,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Respiratory Depression"],"interventions":[{"type":"DRUG","name":"BEMA Fentanyl","otherNames":["bioerodible mucoadhesive","fentanyl buccal soluble film","ONSOLIS"]}],"arms":[{"label":"BEMA Fentanyl","type":"EXPERIMENTAL"}],"summary":"This study is designed to provide continued access to BEMA Fentanyl for those subjects who previously participated in FEN-202 and who wish to continue using BEMA Fentanyl for the treatment of their breakthrough cancer pain.","primaryOutcome":{"measure":"Efficacy Was Not Measured in This Study. The Number of Deaths in the Long Term Follow-up Will be Reported.","timeFrame":"3 years","effectByArm":[{"arm":"BEMA Fentanyl","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}